chr9-136434050-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_019892.6(INPP5E):c.1021G>A(p.Gly341Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000151 in 1,456,540 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_019892.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPP5E | ENST00000371712.4 | c.1021G>A | p.Gly341Ser | missense_variant | Exon 3 of 10 | 1 | NM_019892.6 | ENSP00000360777.3 | ||
INPP5E | ENST00000676019.1 | c.1021G>A | p.Gly341Ser | missense_variant | Exon 3 of 10 | ENSP00000501984.1 | ||||
INPP5E | ENST00000675256.1 | c.250G>A | p.Gly84Ser | missense_variant | Exon 2 of 2 | ENSP00000502517.1 | ||||
INPP5E | ENST00000674513.1 | n.292G>A | non_coding_transcript_exon_variant | Exon 3 of 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000827 AC: 2AN: 241952Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131420
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1456540Hom.: 0 Cov.: 31 AF XY: 0.0000166 AC XY: 12AN XY: 724268
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial aplasia of the vermis Pathogenic:2
- -
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 341 of the INPP5E protein (p.Gly341Ser). This variant is present in population databases (rs780882740, gnomAD 0.002%). This missense change has been observed in individual(s) with Joubert syndrome (PMID: 26092869). ClinVar contains an entry for this variant (Variation ID: 217661). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on INPP5E protein function. For these reasons, this variant has been classified as Pathogenic. -
not provided Uncertain:1
Previously identified in individuals with Joubert syndrome who harbored a second INPP5E variant; however, segregation to determine the phase of the variants was not reported (PMID: 26092869); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23386033, 31964843, 26092869) -
Joubert syndrome 1 Uncertain:1
The heterozygous p.Gly341Ser variant in INPP5E was identified by our study in the compound heterozygous state, along with another variant of uncertain significance, in 1 individual with Joubert syndrome 1. The variant has been reported in 3 individuals of unknown ethnicity with Joubert syndrome 1 (PMID: 26092869), and has been identified in 0.002% (2/109550) of European non-Finnish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs780882740). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 217661) as pathogenic by UW Hindbrain Malformation Research Program, University of Washington. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The phenotype of an individual heterozygous for this variant is highly specific for Joubert syndrome 1 based on unique phenotype consistent with disease. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2, PP4 (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at